ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 128 filers reported holding ANIKA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $285,672 | -50.4% | 11,278 | -50.3% | 0.00% | -33.3% |
| Q1 2024 | $576,529 | -35.6% | 22,698 | -42.6% | 0.00% | -50.0% |
| Q4 2023 | $895,478 | -38.2% | 39,518 | -49.2% | 0.01% | -45.5% |
| Q3 2023 | $1,449,638 | +459.7% | 77,812 | +613.9% | 0.01% | +1000.0% |
| Q3 2022 | $259,000 | -23.6% | 10,900 | -28.2% | 0.00% | -50.0% |
| Q2 2022 | $339,000 | +109.3% | 15,181 | +235.3% | 0.00% | 0.0% |
| Q4 2021 | $162,000 | -44.9% | 4,527 | -41.8% | 0.00% | -60.0% |
| Q2 2020 | $294,000 | -51.4% | 7,783 | -62.8% | 0.01% | -68.8% |
| Q1 2020 | $605,000 | -44.7% | 20,935 | -0.8% | 0.02% | -20.0% |
| Q4 2019 | $1,094,000 | +129.8% | 21,104 | +143.2% | 0.02% | +122.2% |
| Q3 2019 | $476,000 | -13.6% | 8,679 | -36.0% | 0.01% | -10.0% |
| Q2 2019 | $551,000 | +108.7% | 13,570 | +116.5% | 0.01% | -28.6% |
| Q3 2018 | $264,000 | – | 6,267 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
| AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
| CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
| TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
| Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
| OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
| Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
| THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
| DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |